Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction
Open Access
- 20 July 1998
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 188 (2) , 409-414
- https://doi.org/10.1084/jem.188.2.409
Abstract
Naive T cells recirculate mainly within the secondary lymphoid compartment, but once activated they can enter peripheral tissues and perform effector functions. To activate naive T cells, foreign antigens must traffic from the site of infection to the draining lymph nodes, where they can be presented by professional antigen presenting cells. For major histocompatibility complex class I–restricted presentation to CD8+ T cells, this can occur via the cross-presentation pathway. Here, we investigated the conditions allowing antigen access to this pathway. We show that the level of antigen expressed by peripheral tissues must be relatively high to facilitate cross-presentation to naive CD8+ T cells. Below this level, peripheral antigens did not stimulate by cross-presentation and were ignored by naive CD8+ T cells, although they could sensitize tissue cells for destruction by activated cytotoxic T lymphocytes (CTLs). Interestingly, CTL-mediated tissue destruction facilitated cross-presentation of low dose antigens for activation of naive CD8+ T cells. This represents the first in vivo evidence that cellular destruction can enhance access of exogenous antigens to the cross-presentation pathway. These data indicate that the cross-presentation pathway focuses on high dose antigens and those released during tissue destruction.Keywords
This publication has 26 references indexed in Scilit:
- Induction of Autoimmune Diabetes by Oral Administration of AutoantigenScience, 1996
- A new foreign policy: MHC class I molecules monitor the outside worldImmunology Today, 1996
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994
- The Biochemistry and Cell Biology of Antigen Processing and PresentationAnnual Review of Immunology, 1993
- A fail-safe mechanism for maintaining self-tolerance.The Journal of Experimental Medicine, 1992
- Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune responseCell, 1991
- Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic miceCell, 1991
- Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.The Journal of Experimental Medicine, 1990
- Minor but not major histocompatibility antigens of thymus epithelium tolerize precursors of cytolytic T cellsNature, 1986
- Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.The Journal of Experimental Medicine, 1976